Publication

Tryptophan metabolism in aging and disease: Insights from Caenorhabditis elegans

Michels, H., 2017, [Groningen]: University of Groningen. 270 p.

Research output: ThesisThesis fully internal (DIV)Academic

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 878 KB, PDF document

  • Chapter I

    Final publisher's version, 823 KB, PDF document

  • Chapter II

    Final publisher's version, 1 MB, PDF document

  • Chapter III

    Final publisher's version, 2 MB, PDF document

  • Chapter IV

    Final publisher's version, 641 KB, PDF document

  • Chapter V

    Final publisher's version, 802 KB, PDF document

  • Chapter VI

    Final publisher's version, 1 MB, PDF document

  • Chapter VII

    Final publisher's version, 3 MB, PDF document

  • Chapter VIII

    Final publisher's version, 573 KB, PDF document

  • Chapter IX

    Final publisher's version, 414 KB, PDF document

  • Summary

    Final publisher's version, 259 KB, PDF document

  • Samenvatting

    Final publisher's version, 260 KB, PDF document

  • List of publications

    Final publisher's version, 264 KB, PDF document

  • Appendix

    Final publisher's version, 500 KB, PDF document

  • Acknowledgements

    Final publisher's version, 249 KB, PDF document

  • Complete thesis

    Final publisher's version, 9 MB, PDF document

  • Propositions

    Final publisher's version, 186 KB, PDF document

  • Helen Michels
The increasing lifespan of the world’s population in the last few decades correlates with an increasing number of people with age-related disease. Tryptophan metabolism is involved in various age-related pathologies such as neurodegeneration, cancer and diabetes type 2, which attracted the attention for therapeutic interventions. In model organisms for cancer and neurodegeneration, inhibition of the tryptophan-degrading enzyme, tryptophan- 2,3 dioxygenase (TDO), improves health- and extends lifespan. Tryptophan metabolites play a role but do not explain all protective effects. This thesis is aimed to better understand how the nutrient tryptophan and its metabolism influences the aging process and how it acts in the development of age-related neurodegenerative pathologies.
Findings in this thesis were obtained with the help of the small nematode Caenorhabditis elegans, a model organism which enables easy genetic manipulation and in vivo longevity experiments.
We identified a new tryptophan metabolite-independent function of TDO: the regulation of mitochondrial energy metabolism. Other amino acid dioxygenases appear to regulate mitochondrial function, health- and lifespan in a similar manner. Mitochondria do play a central role in the aging process and their dysregulation is often a characteristic of age-related pathologies.
Furthermore, we identified an evolutionary conserved region in the TDO protein that is essential for the enzyme’s function and might be used as a target for the development of new TDO inhibitors.
Our results indicate that the inhibition of TDO or other amino acid dioxygenases can be explored as a therapeutic strategy to control mitochondrial metabolism, slow down aging and ameliorate age-related pathologies.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
Award date27-Sep-2017
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-028-0754-7
Electronic ISBNs978-94-034-0179-9
Publication statusPublished - 2017

Download statistics

No data available

ID: 48321653